ERBB2 and non-small cell lung carcinoma: Most of patients with ERBB2 mutation were with in-frame insertions in exon 20 (ERBB2-ex20ins) mutation, which were found about 1.7% incidence in NSCLC patients (Mazières et al. 2013).